Nehal M Ramadan
Overview
Explore the profile of Nehal M Ramadan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
24
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Abdulgalil A, Elnagdy N, Ramadan N, Hamza E, Hammad A, Korkor M, et al.
Pediatr Rheumatol Online J
. 2025 Mar;
23(1):26.
PMID: 40075510
Introduction: Mycophenolate Mofetil (MMF) has become one of the cornerstone treatments of lupus nephritis (LN). It is converted into mycophenolic acid (MPA), an active metabolite, that displays high inter- and...
2.
Eraky S, Ramadan N, Atif H, Mahmoud A, Abo El-Magd N
Life Sci
. 2024 Dec;
361:123327.
PMID: 39716568
Obesity and its associated intestinal inflammatory responses represent a significant global challenge. (IF) is a dietary intervention demonstrating various health benefits, including weight loss, enhanced metabolic health, and increased longevity....
3.
Samaan E, Ramadan N, Abdulaziz H, Ibrahim D, El-Sherbiny M, Elbayar R, et al.
Biomed Pharmacother
. 2023 Oct;
167:115629.
PMID: 37804810
Rationale: Renal hypoxia is one of the currently highlighted pathophysiologic mechanisms of diabetic nephropathy (DN). Both hypoxia-inducible factor-1α (HIF-1α) and HIF-2α are major regulators of renal adaptive responses to hypoxia....
4.
Ramadan N, Barbosa P, Abo El-Magd N, Eraky S, Al-Gayyar M
Front Pharmacol
. 2023 Aug;
14:1266168.
PMID: 37614313
No abstract available.
5.
Atia A, Ashour R, Zaki M, Rahman K, Ramadan N
Psychopharmacology (Berl)
. 2023 May;
240(6):1313-1332.
PMID: 37133558
Rationale: Risperidone is the first antipsychotic to be approved by Food and Drug Administration (FDA) for treating autism spectrum disorder (ASD). The potential efficacy of metformin in preventing and/or controlling...
6.
Abbas E, Ezzat M, Ramadan N, Eladl A, Hamed W, Abdel-Aziz M, et al.
Food Funct
. 2023 Mar;
14(7):3107-3125.
PMID: 36942614
(L.) Miller (OFI), belonging to the family Cactaceae, is widely cultivated not only for its delicious fruits but also for its health-promoting effects, which enhance the role of OFI as...
7.
Eraky S, Ramadan N, Abo El-Magd N
Int J Biol Macromol
. 2022 Dec;
227:1119-1131.
PMID: 36462588
Alzheimer's disease (AD) is known as "type 3 diabetes". As thioredoxin binding protein (TXNIP) has been shown to be involved in brain insulin resistance, the present study evaluated the roles...
8.
Ramadan N, Elmasry K, Elsayed H, El-Mesery A, Eraky S
Life Sci
. 2022 Nov;
311(Pt A):121145.
PMID: 36336129
Aim: We compared the efficacy of n3-polyunsaturated fatty acids (n3-PUFAs) and metformin in halting the progression of non-alcoholic fatty liver disease (NAFLD) developed in the milieu of insulin deficiency. Main...
9.
Eraky S, Ramadan N, Abo El-Magd N
Cell Biochem Funct
. 2021 Dec;
40(1):90-102.
PMID: 34855213
The study was designed to assess the possible augmented antidiabetic effects of combining quercetin and liraglutide in a type 1 diabetes model, with emphasis on the contribution of hepatic thioredoxin...
10.
Abo El-Magd N, Ramadan N, Eraky S
Life Sci
. 2021 Sep;
285:119982.
PMID: 34592232
Aims: Diabetes, a serious worldwide problem, is modulated via inflammation and oxidative stress. Bromelain, a natural compound, recently attracts interest due to its anti-inflammatory effects, while its mode of action...